Advances in Vaccines, Checkpoint Blockade, and Chimeric Antigen Receptor-Based Cancer Immunotherapeutics

被引：0
|
作者：
Agarwal, Disha [1 ]
Sharma, Gaurav [1 ]
Khadwal, Alka [2 ]
Toor, Devinder [3 ]
Malhotra, Pankaj [2 ]
机构：
[1] Postgrad Inst Med Educ & Res, Dept Translat & Regenerat Med, 5th Floor Res Block B Sect 12, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Clin Hematol & Med Oncol, Chandigarh, India
[3] Amity Univ Uttar Pradesh, Amity Inst Virol & Immunol, Noida, India
来源：
CRITICAL REVIEWS IN IMMUNOLOGY | 2024年 / 45卷 / 01期
关键词：
vaccines; cancer; immunotherapy; CTLA-4; PD-1; CAR-T cells; CAR-NK cells; immune surveillance; immune exhaustion; MESSENGER-RNA VACCINES; NATURAL-KILLER-CELLS; T-CELLS; DENDRITIC CELLS; NK-92; CELLS; CD28; GENERATION; RESISTANCE; THERAPY; PD-1;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Increase in cancer cases and research driven by understanding its causes, facilitated development of novel targeted immunotherapeutic strategies to overcome nonspecific cytotoxicity associated with conventional chemotherapy and radiotherapy. These target specific immunotherapeutic regimens have been evaluated for their efficacy, including: (1) vaccines harnessing tumor specific/associated antigens, (2) checkpoint blockade therapy using monoclonal antibodies against PD1, CTLA-4 and others, and (3) adoptive cell transfer approaches viz. chimeric antigen receptor (CAR)-cellbased therapies. Here, we review recent advancements on these target specific translational immunotherapeutic strategies against cancer/s and concerned limitations.
引用
收藏
页码：65 / 80
页数：16
相关论文
共 50 条
  • [1] Chimeric antigen receptor-based immunotherapy in breast cancer: Recent progress in China
    Yu, Tianze
    Lu, Yuexin
    Fang, Jianwen
    Jiang, Xiaocong
    Lu, Yue
    Zheng, Jingyan
    Shang, Xi
    Shen, Haixing
    Fu, Peifen
    CANCER, 2024, 130 : 1378 - 1391
  • [2] Chimeric antigen receptor-based therapies beyond cancer
    Velasco-de Andres, Maria
    Munoz-Sanchez, Guillermo
    Carrillo-Serradell, Laura
    Gutierrez-Hernandez, Maria del Mar
    Catala, Cristina
    Isamat, Marcos
    Lozano, Francisco
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 (03)
  • [3] Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
    Hegde, Upendra P.
    Mukherji, Bijay
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (09) : 1113 - 1121
  • [4] Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
    Upendra P. Hegde
    Bijay Mukherji
    Cancer Immunology, Immunotherapy, 2017, 66 : 1113 - 1121
  • [5] Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor-Based Immunotherapy and Chemotherapy
    Klapdor, Ruediger
    Wang, Shuo
    Hacker, Ulrich
    Buening, Hildegard
    Morgan, Michael
    Doerk, Thilo
    Hillemanns, Peter
    Schambach, Axel
    HUMAN GENE THERAPY, 2017, 28 (10) : 886 - 896
  • [6] Potential of chimeric antigen receptor (CAR)-redirected immune cells in breast cancer therapies: Recent advances
    Nikoo, Marzieh
    Rudiansyah, Mohammad
    Bokov, Dmitry Olegovich
    Jainakbaev, Nurlan T.
    Suksatan, Wanich
    Ansari, Mohammad Javed
    Thangavelu, Lakshmi
    Chupradit, Supat
    Zamani, Amir
    Adili, Ali
    Shomali, Navid
    Akbari, Morteza
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (15) : 4137 - 4156
  • [7] Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma
    Pang, Yifan
    Ghosh, Nilanjan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [8] Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
    Zhang, Beibei
    Yang, Mengzhe
    Zhang, Weiming
    Liu, Ning
    Wang, Daogang
    Jing, Liangfang
    Xu, Ning
    Yang, Na
    Ren, Tao
    CELL DEATH & DISEASE, 2024, 15 (01)
  • [9] Engineering chimeric antigen receptor-natural killer cells for cancer immunotherapy
    Zhao, Yu
    Zhou, Xiaorong
    IMMUNOTHERAPY, 2020, 12 (09) : 653 - 664
  • [10] Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy
    Shin, Seungyong
    Lee, Pyunghwajun
    Han, Jieun
    Kim, Se-Na
    Lim, Jaesung
    Park, Dae-Hwan
    Paik, Taejong
    Min, Junhong
    Park, Chun Gwon
    Park, Wooram
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2023, 20 (03) : 371 - 387
12345